Evidence map›Paper›PMID 40303226›Full record

ArticleKidney international reports2025

Corrigendum to "Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy" [Volume 10, Issue 1, January 2025, Pages 217-226].

Hiddo J L Heerspink, Meg Jardine, Donald E Kohan, Richard A Lafayette, Adeera Levin, Adrian Liew, Hong Zhang, Irene Noronha, Hernan Trimarchi, Fan Fan Hou and 4 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney international reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Hiddo J L HeerspinkDepartment of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Meg JardineThe George Institute for Global Health, Syndey, Australia.
Donald E KohanDivision of Nephrology, University of Utah Health, Salt Lake City, Utah, USA.
Richard A LafayetteDivision of Nephrology, Stanford University, Stanford, California, USA.
Adeera LevinDivision of Nephrology, The University of British Columbia, Vancouver, British Columbia, Canada.
Adrian LiewThe Kidney and Transplant Practice, Mount Elizabeth Novena Hospital, Singapore, Singapore.
Hong ZhangRenal Division, Peking University First Hospital, Beijing, Beijing, China.
Irene NoronhaRenal Division, Hospital Beneficência Portuguesa de São Paulo, São Paulo, Brazil.
Hernan TrimarchiDivision of Nephrology and Renal Transplantation, Hospital Británico de Buenos Aires, Buenos Aires, Argentina.
Fan Fan HouDivision of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, Guangzhou, China.
Ronny RenfurmNovartis Pharmaceuticals AG, Basel, Switzerland.
Todd GrayChinook Therapeutics, A Novartis Company, Seattle, Washington, USA.
Marianne CamargoChinook Therapeutics, A Novartis Company, Seattle, Washington, USA.
Jonathan BarrattDepartment of Cardiovascular Sciences, University of Leicester, Leicester, Leicestershire, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1016/j.ekir.2024.10.004.].

Identifiers

PMID40303226
PMCPMC12034857

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.